This article is from the source 'bbc' and was first published or seen on . The next check for changes will be
You can find the current article at its original source at https://www.bbc.co.uk/news/health-55274833
The article has changed 169 times. There is an RSS feed of changes available.
Previous version
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
Next version
Version 2 | Version 3 |
---|---|
Covid vaccine: How will the UK jab millions of people? | Covid vaccine: How will the UK jab millions of people? |
(21 days later) | |
The UK has launched its biggest mass-vaccination programme, aimed at protecting tens of millions of people from Covid-19 within months. | |
In a race against a faster-spreading variant of coronavirus, ministers have pinned their hopes of ending a third national lockdown on protecting the most vulnerable groups by spring. | |
But there are huge challenges, not least the unprecedented scale but also the need for rigorous safety checks and deep-freeze storage as well as establishing enough vaccination centres and recruiting enough vaccinators. | |
What is the plan? | |
The government aims to offer vaccines to 15 million people - the over-70s, healthcare workers and those required to shield - by mid-February and millions more by spring. | |
The speedy rollout of the vaccine to vulnerable people is seen as critical to reducing the pandemic's death toll and relieving pressure on the NHS. | |
But to meet this target, ministers need to deliver more than two million jabs a week by the end of January, in one of the largest civilian logistical operations launched in Britain. | |
Since the beginning of last month, 1.5 million people have been vaccinated, Prime Minister Boris Johnson has said. But more than 13 million people will need to receive jabs in the next five weeks. And the UK's chief medical adviser, Prof Chris Whitty, has described such a timetable as "realistic but not easy". | |
The NHS began administering a vaccine made by Pfizer-BioNTech. | |
But the operation is being significantly ramped up following the approval of a second vaccine, from Oxford University and AstraZeneca. | |
A third vaccine from Moderna was approved on Friday. | |
And the campaign to reach as many people as possible as quickly as possible has also been boosted by a shift in policy - to prioritise the first dose of either vaccine, with a second dose up to 12 weeks later, a bigger gap than originally planned. | |
On Thursday, Mr Johnson said it would require an "unprecedented national effort" but the government was throwing "everything at it" to deliver "hundreds of thousands" of jabs each day. | |
Can we jab our way out of lockdown? | |
Will a vaccine give us our old lives back? | |
Covid vaccine: When will you be eligible? | |
Where are the vaccines coming from? | |
The UK is currently receiving doses of two vaccines approved by the medicine regulator. The Pfizer-BioNTech jab - the first given the green light - is being imported from Puurs, Belgium. Meanwhile, the Oxford vaccine is being made in Britain, by two biotech companies: | |
Oxford BioMedica, based in Oxford | |
Cobra Biologics, based at Keele Science Park, Staffs | |
Another company, Wockhardt, based in Wrexham, fills the vials and packages them for use | |
But the country's initial doses of the Oxford vaccine will actually come from Europe, UK Vaccine Taskforce manufacturing lead Ian McCubbin has said. | |
Supplies of the third vaccine to be approved, made by US company Moderna, are not expected to be available until spring. | |
Is there a hold-up? | |
There are a number of challenges in what is called the vaccine "supply chain" - the logistics of how the jab gets from manufacturers to people. | |
One challenge facing pharmaceutical companies globally has been a shortage of glass vials for the "fill and finish" stage of manufacture - when a vaccine is packaged for despatch. Although, unlike elsewhere, the UK is thought currently to have enough of this glassware in storage. | |
On top of this, Mr Johnson has referred to the "rate-limiting factor" of batch testing - the process of ensuring vaccines released by manufacturers are safe and up to standard. | |
The UK's Medicines and Healthcare Products Regulatory Authority (MHRA) requires vaccines to be checked by the National Institute of Biological Standards and Control (NIBSC) to ensure they are: | |
effective | |
structurally intact | |
free of contaminants | |
And this process can take a long time as it has to be done twice - before the vaccine enters vials and after. | |
Testing a batch is sterile takes two weeks. | |
An MHRA spokesman said it was working closely with AstraZeneca "to ensure that batches of the vaccine are released as quickly as possible". And the NIBSC had scaled up its capacity so "multiple batches can be tested simultaneously". More technical staff are also being taken on. | |
The UK's Vaccines Manufacturing and Innovation Centre chief executive Matthew Duchars says preparing enough vaccine is "quite a challenge" given the timeframe but "doable". | |
"It's not like we haven't done this before," he says. "But we've not done it so quickly before." | |
How is the vaccine transported? | |
The Oxford vaccine can be stored in fridges and transported in regular refrigerated vans or cool boxes. But the Pfizer jab - made from genetic material - needs to be stored at -70C to prevent it from degrading. | |
This means it needs to be transported in a carefully controlled deep-freeze delivery chain, with vials placed inside special ultra-cold thermal boxes, known as "shippers". | |
These boxes - fitted with temperature-monitoring devices - are taken by plane or lorry to the UK and onward to their destination. Once at a vaccination site, the consignment needs to be removed from cold storage by specially trained NHS staff and takes a few hours to defrost before being diluted in saline and given to patients. | |
The newly-approved Moderna jab requires temperatures of around -20C for shipping - similar to a normal freezer. | |
How will people be vaccinated? | |
People will be vaccinated in three main ways, at: | |
local GP practices and community pharmacies | |
hospital hubs | |
mass vaccination sites across the country | |
About 1,000 GP sites, 200 community pharmacies, 223 hospital hubs and seven mass vaccination sites should be up and running by next week. And the prime minister says no-one should have to travel more than 10 miles for a jab. | |
The first seven mass vaccination centres are: | |
Robertson House, in Stevenage, Herts | |
the ExCel Centre, in London | |
the Centre for Life, in Newcastle | |
the Etihad tennis centre, in Manchester | |
Epsom Downs Racecourse, in Surrey | |
Ashton Gate Stadium, in Bristol | |
Millennium Point, in Birmingham | |
In Scotland, as well as GPs surgeries and hospital hubs, Motherwell Concert Hall and The Event Complex Aberdeen are being considered alongside sports venues. | |
So far, 80,000 people have been trained to deliver the vaccines, NHS boss Sir Simon Stevens says, with thousands more set to join the effort. The charity St John Ambulance Brigade is among those helping out. | |
And a further 21 quick-reaction vaccination teams will also be ready to deployed anywhere around the country, commander of military support to the vaccine delivery programme Brig Phil Prosser says. | |
Who will be vaccinated? | |
While the NHS administers about 15 million flu vaccines across the UK every year, with all four nations achieving some of the highest vaccination rates among the over-65s in Europe, the scale and speed of the Covid jab rollout is unprecedented. | |
The aim is to inoculate as many people as possible aged over 16 in the UK. The most vulnerable take priority, as set out in a list of nine high-priority groups, covering about a quarter of the UK population. They are thought to represent 90-99% of those at risk of dying from Covid-19. | The aim is to inoculate as many people as possible aged over 16 in the UK. The most vulnerable take priority, as set out in a list of nine high-priority groups, covering about a quarter of the UK population. They are thought to represent 90-99% of those at risk of dying from Covid-19. |
People aged over 80, front-line health staff and care home workers have been some of the first to receive the Pfizer jab. | |
GPs and local vaccination centres have been asked to ensure every care-home resident in their area is vaccinated by the end of January. | |
Together, care home residents, their carers and the over-80s make up an estimated 4.5 million people, while front-line NHS staff make up a further 1.6 million. | |
Is there enough vaccine? | |
The UK has ordered 100 million doses of the Oxford vaccine - enough to inoculate 50 million people. | |
This, when combined with the 40 million ordered Pfizer jabs, will cover the entire population, Health Secretary Matt Hancock has said. | |
The UK also has significant orders of the newly-approved Moderna vaccine and four other candidates. | |
But having vaccines on order is not the same as having them ready to go. Of the 100 million Oxford jabs ordered, only 530,000 were ready for nationwide rollout on 4 January. Although, the government has said this number will rise to "tens of millions" by the end of March. | |
Meanwhile, the UK has taken delivery of 22 consignments of the 40 million Pfizer jabs ordered. | |
And Pfizer says the number it has sent to the UK is now "in the millions". | |
LOOK-UP TOOL: How many cases in your area? | |
YOUR QUESTIONS: We answer your queries | |
GLOBAL SPREAD: How many worldwide cases are there? | |
THE R NUMBER: What it means and why it matters | |
TEST AND TRACE: How does it work? | |
Design by Lilly Huynh, Irene de la Torre Arenas and Sana Jasemi. Additional reporting by Smitha Mundasad |
Previous version
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
Next version